Pierre-Yves Abécassis
Sanofi (France)(FR)Smiths Detection (France)(FR)Ages et Vie(FR)
Publications by Year
Research Areas
Estrogen and related hormone effects, Computational Drug Discovery Methods, Advanced Breast Cancer Therapies, PI3K/AKT/mTOR signaling in cancer, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → The Circadian Clock Components CRY1 and CRY2 Are Necessary to Sustain Sex Dimorphism in Mouse Liver Metabolism(2009)111 cited
- → Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors(2014)90 cited
- → Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer(2019)81 cited
- → SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models(2020)66 cited
- → SAR156497, an Exquisitely Selective Inhibitor of Aurora Kinases(2014)38 cited
- →